You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 3, March 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Neurogenetics
 •Neuromuscular diseases
 •Alert me on articles by topic

Reduced Aquaporin 4 Expression in the Muscle Plasma Membrane of Patients With Duchenne Muscular Dystrophy

Yoshihiro Wakayama, MD, PhD; Takahiro Jimi, MD; Masahiko Inoue, MD; Hiroko Kojima, BS; Makoto Murahashi, MD; Toshiyuki Kumagai, MD; Sumimasa Yamashita, MD; Hajime Hara, MD; Seiji Shibuya, MD

Arch Neurol. 2002;59:431-437.

Background  In Duchenne muscular dystrophy (DMD), previous freeze-fracture electron microscopic studies demonstrated that muscle plasma membrane contained markedly decreased numbers of orthogonal arrays. Recent investigations showed that orthogonal arrays were composed of aquaporin 4 (AQP4) molecules, a member of the water channel protein family.

Objectives  To study whether the immunostainability of anti-AQP4 antibody is reduced in muscles of patients with DMD and whether, if it is reduced, the problem is at the genomic DNA, messenger RNA (mRNA), or posttranscriptional level.

Patients and Methods  We analyzed the muscle and blood samples from 6 boys with DMD, 6 normal control subjects, and 12 patients with neuromuscular diseases at the protein, genomic DNA, and mRNA levels. At the protein level, immunohistochemical staining and immunoblot analysis were performed. At the genomic DNA and mRNA levels, the polymerase chain reaction and reverse transcription polymerase chain reaction, respectively, were used to screen for mutations in the AQP4 gene.

Results  At the protein level, immunohistochemical staining of our originally generated rabbit anti-AQP4 antibody in DMD muscles was markedly reduced. Most of the DMD myofibers showed negative staining with sporadic partially positive fibers at their myofiber surface, whereas the control muscles displayed continuous myofiber surface staining. Immunoblot analysis showed that the content of AQP4 in DMD muscles was remarkably decreased. Amplification of leukocyte genomic DNA by polymerase chain reaction showed that the patients with DMD had genomic DNA of the AQP4 molecule. Quantitative reverse transcription polymerase chain reaction demonstrated that DMD skeletal muscles contained markedly decreased AQP4 mRNA compared with controls.

Conclusion  The reduction in AQP4 in DMD muscles results from decreased levels of AQP4 mRNA in DMD myofibers.


From the Department of Neurology, Showa University Fujigaoka Hospital, Yokohama (Drs Wakayama, Jimi, Inoue, Murahashi, Hara, and Shibuya and Ms Kojima); Department of Pediatric Neurology, Aichi Prefectural Colony, Kasugai (Dr Kumagai); and Department of Neurology, Kanagawa Children's Medical Center, Yokohama (Dr Yamashita), Japan.


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(3):492-494.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Novel variants in human Aquaporin-4 reduce cellular water permeability
Sorani et al.
Hum Mol Genet 2008;17:2379-2389.
ABSTRACT | FULL TEXT  

The relationship between intramembranous particles and aquaporin molecules in the plasma membranes of normal rat skeletal muscles: a fracture-label study
Shibuya et al.
J Electron Microsc (Tokyo) 2006;55:63-68.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.